Why the study?
Does concomitant hyperlipidaemia affect 5-year survival in patients hospitalized for acute myocardial infarction?
Does concomitant hyperlipidaemia affect 5-year survival in patients hospitalized for acute myocardial infarction?
Concomitant hyperlipidaemia is paradoxically associated with increased 5-year survival after acute myocardial infarction, independent of statin therapy.
Answers are grounded in this paper and cite their sources.
Concomitant hyperlipidaemia was associated with better post-AMI survival independent of statins; this observational finding leaves open confounding and should not change practice.
In patients with AMI, concomitant HLP was associated with increased survival and a net gain in life years, independent of survival benefit from statin therapy. The results also reaffirm the role of statin prescription, intensity and adherence in reducing the mortality after incident AMI.
No takes yet. Share an insight, caveat, or question.
Yousufuddin et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: